[2] [11] As of 2026, retatrutide has not received marketing authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency (EMA), and it remains an experimental compound available only within authorised clinical trial settings
It is also commonly used in skincare and hair-care formulations due to its regenerative properties
Some people may experience minor digestive adjustments when starting a new supplement, but these typically resolve quickly
J Biol Chem 72:147 Jagadeesh SL, Charles MT, Garipy Y, Goyette B, Raghavan VGS, Vigneault C (2011) Influence of postharvest UV-C hormesis on the bioactive components of tomato during post-treatment handling
Plasma homocysteine level in children with postural tachycardia syndrome
Prioritize sleep quality and stress management to support regenerative biological processes